Corporate
Lilly Stock Drops 4% as FDA Delays Obesity Pill, Handing Novo Crucial Head Start
5d ago
You're signed outSign in or to get full access.
Leadership at ELI LILLY &
Browse executives, board members, and key leadership.
Executives at ELI LILLY &
Board Members at ELI LILLY &
Recent News about ELI LILLY &
Policy & Geopolitics
FDA Removes Suicide Warnings From Blockbuster Weight-Loss Drugs Wegovy and Zepbound
Jan 13
Deals & Capital Markets
Eli Lilly Eyes €15 Billion Abivax Takeover as Pharma M&A Heats Up
Jan 12
Deals & Capital Markets
Aktis Oncology Raises $318M in 2026's First Biotech IPO, Lilly Takes $100M Stake
Jan 9
Corporate
Lilly's Zepbound-Taltz Combo Delivers 40x Response Rate in First-of-Its-Kind Arthritis-Obesity Trial
Jan 8
Deals & Capital Markets
Eli Lilly Nears $1B+ Ventyx Deal as TYK2 Arms Race Heats Up
Jan 7